Sarepta Therapeutics Inc.

NASDAQ: SRPT · Real-Time Price · USD
62.80
0.40 (0.64%)
At close: May 01, 2025, 3:59 PM
62.60
-0.31%
After-hours: May 01, 2025, 07:49 PM EDT

Sarepta Therapeutics Revenue Breakdown

Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
A M O N D Y S Fourty Five Revenue 26.66M 6.94M 193K
A M O N D Y S Fourty Five Revenue Growth +284.30% +3493.78% n/a
E X O N D Y S Fifty One Revenue 115.6M 112.46M 107.19M
E X O N D Y S Fifty One Revenue Growth +2.79% +4.92% n/a
V Y O N D Y S Fifty Three Revenue 24.66M 22.44M 17.55M
V Y O N D Y S Fifty Three Revenue Growth +9.87% +27.89% n/a

Revenue by Geography

Period Ending Dec 31, 2023 Dec 31, 2022
United States Revenue 797.94M 747.1M
United States Revenue Growth +6.81% n/a
Rest Of World Revenue 146.58M n/a
Rest Of World Revenue Growth n/a n/a

Operating Expense Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 128.2M 136.66M 127M 131.7M 120.89M 118.56M 110.71M 120.48M 104.79M 154.32M 71.84M 78.06M 61.13M 72.35M 71.13M 86.05M 75.37M 73.69M 82.77M 81.42M 75.43M 67.39M 60.57M 64.22M 53.04M 49.38M 43.34M 32.22M 28.18M 36.07M 26.22M 22.94M 22.18M 17.75M 20.88M 24.33M 15.09M 12.93M 22.7M
Selling, General, and Administrative Revenue Growth -6.19% +7.60% -3.57% +8.94% +1.96% +7.09% -8.10% +14.97% -32.10% +114.81% -7.96% +27.69% -15.51% +1.71% -17.33% +14.16% +2.29% -10.97% +1.65% +7.95% +11.92% +11.27% -5.69% +21.07% +7.42% +13.93% +34.51% +14.36% -21.88% +37.58% +14.30% +3.39% +24.97% -14.96% -14.19% +61.23% +16.73% -43.05% n/a
Research and Development Revenue 224.48M 173.71M 194.35M 195.52M 194.3M 241.89M 245.68M 213.8M 216.71M 252.33M 194.25M 197.3M 139.12M 239.62M 195.15M 207.24M 190.44M 188.52M 136.14M 223.14M 133.95M 113.27M 90.55M 146.21M 86.58M 122.85M 46.2M 44.44M 34.24M 58.91M 29.12M 70.75M 34.35M 44.35M 38.83M 41.38M 36.67M 29.18M 39.16M
Research and Development Revenue Growth +29.23% -10.62% -0.60% +0.63% -19.67% -1.54% +14.91% -1.34% -14.12% +29.90% -1.54% +41.82% -41.94% +22.79% -5.83% +8.82% +1.02% +38.47% -38.99% +66.59% +18.26% +25.08% -38.07% +68.86% -29.52% +165.88% +3.97% +29.80% -41.88% +102.30% -58.84% +105.97% -22.55% +14.22% -6.16% +12.82% +25.68% -25.49% n/a